Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Colorcon
US Army
Baxter
Teva
Johnson and Johnson
Mallinckrodt
US Department of Justice
Daiichi Sankyo

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,460,704

« Back to Dashboard

Which drugs does patent 8,460,704 protect, and when does it expire?

Patent 8,460,704 protects VIRAMUNE XR and is included in one NDA.

This patent has thirty patent family members in twenty-seven countries.
Summary for Patent: 8,460,704
Title:Extended release formulation of nevirapine
Abstract: The invention relates to an extended release pharmaceutical composition comprising nevirapine.
Inventor(s): Cappola; Michael L. (Malvern, PA), Sienkiewicz; Svetlana (New Milford, CT), Snow; Glenn Charles (Sandy Hook, CT), Chen; Feng-Jing (Danbury, CT)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
Application Number:12/523,226
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 8,460,704

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Boehringer Ingelheim VIRAMUNE XR nevirapine TABLET, EXTENDED RELEASE;ORAL 201152-001 Mar 25, 2011 AB RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT OF HIV-1 BY ONCE DAILY ADMINISTRATION ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,460,704

PCT Information
PCT FiledJune 04, 2008PCT Application Number:PCT/US2008/065705
PCT Publication Date:December 18, 2008PCT Publication Number: WO2008/154234

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Department of Justice
Daiichi Sankyo
Healthtrust
Baxter
McKinsey
Queensland Health
Merck
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.